The Endocrine Society is pleased to offer the Rare Endocrine Disease (RED) Fellows Program, a blended learning experience offered exclusively to endocrinology fellows. Developed in partnership with the National Organization for Rare Disorders (NORD), this program addresses critical gaps in awareness, diagnosis, and care of rare endocrine diseases, equipping fellows with the knowledge and practical skills to improve patient outcomes. Fellowship Program Directors and other faculty are invited to nominate fellows to participate in the program.
The RED Fellows Program is an exclusive, application-based educational activity for current fellows and offers multiple modes of learning, including:
- An immersive in-person workshop held at the Endocrine Society Headquarters in downtown Washington, D.C., where fellows engage directly with leading experts in rare endocrine diseases and participate in interactive, case-based discussions.
- Five on-demand courses featuring short micro-lessons covering individual rare endocrine diseases
- RED Fellows Pocket Guide: a static, digital compilation of additional RED resources and key information presented on each disease
The program accepts up to 50 US-domestic fellows for full participation in the in-person program. Travel, 2-night hotel accommodation, and meal expenses will be covered by the Endocrine Society.
The deadline to nominate a fellow is March 2, 2026.
Learning Objectives
Upon successful completion of these educational initiatives, participants should be better able to:
- Recognize the complex symptom patterns and telltale signs of various REDs.
- Implement appropriate, evidence-based and emerging screening strategies (i.e., genetic testing) for rare diseases to mitigate testing-associated patient costs, diagnostic delay, and achieve differential diagnosis.
- Assess risk factors for disease or treatment complications in individuals with REDs, particularly in cases of comorbidities.
- Devise individualized treatment strategies that account for patient history, transitions in care, and socioeconomic factors to manage those with REDs.
- Apply evidence-based approaches in the treatment and symptom management of rare diseases when approved therapies are unavailable to improve long-term outcomes of individuals with REDs.
RED Fellows 2026 Agenda
The in-person program will take place at the Endocrine Society Headquarters in Washington, DC. (All times are Eastern Time) (Subject to Change)
Friday, April 17
- 6:00-7:00 PM ET | Welcome Reception and Dinner
- 7:00- 8:30 PM ET | Keynote Address
Saturday, April 18
- 8:00 AM-9:00 AM ET | Breakfast
- 9:00 AM-11:00 AM ET | Morning Lectures
- 11:00 AM-12:00 PM ET | Patient Panel
- 12:00 PM-1:00 PM ET | Lunch
- 1:00 PM-3:00 PM ET | Afternoon Lectures
- 3:00 PM-4:00 PM ET | Case Study Workshop
- 4:00 PM-5:00 PM ET | Ask the Experts
On-Demand Program
- Bone & Mineral Rare
- HPA Axis
- Metabolic/Lipids
- Reproductive
- Neuroendocrine Tumors (NETs)
This program is supported by educational grants from Alexion Pharmaceuticals, Inc., Neurocrine Biosciences, Inc., BridgeBio Pharma, Inc., Chiesi USA,Inc., Corcept Therapeutics, Inc., and Crinetics Pharmaceuticals, Inc.
